Decker Retirement Planning’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.97K Buy
71
+66
+1,320% +$3.42K ﹤0.01% 280
2026
Q1
$254 Buy
+5
New +$233 ﹤0.01% 275
2025
Q1
Sell
-12
Closed -$499 450
2024
Q4
$499 Buy
+12
New +$574 ﹤0.01% 544

Other funds holding MRNA

Decker Retirement Planning's MRNA Position: Q2 2026 in Review

Decker Retirement Planning increased its Moderna (MRNA) stake by 1,320% in Q2 2026, buying an estimated $3.42K and bringing the position to 71 shares worth $4.97K. The position accounts for ﹤0.01% of the portfolio, ranked #280.

Decker Retirement Planning first reported a position in MRNA in Q4 2024 and has held it in 3 quarters since. 775 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Decker Retirement Planning held 71 shares of Moderna worth $4.97K as of Q2 2026.
  • Decker Retirement Planning bought 66 Moderna shares in Q2 2026, an estimated $3.42K.
  • Moderna made up ﹤0.01% of Decker Retirement Planning's portfolio in Q2 2026, its #280 holding.
  • Decker Retirement Planning first reported a position in Moderna in Q4 2024 and has held it in 3 quarters since.
  • 775 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Decker Retirement Planning's 13F filing for Q2 2026, filed 16 Jul 2026.